123 filings
8-K
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
10-K/A
2023 FY
NKGN
NKGen Biotech Inc
Annual report (amended)
29 Apr 24
5:20pm
8-K
NKGN
NKGen Biotech Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
NKGN
NKGen Biotech Inc
24 Apr 24
Entry into a Material Definitive Agreement
7:51pm
10-K
2023 FY
NKGN
NKGen Biotech Inc
Annual report
16 Apr 24
3:07pm
8-K
lxim7q lq
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
yfay00zhue6cejh3sq28
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
NT 10-K
1z0 t1knl5h2
1 Apr 24
Notice of late annual filing
4:01pm
8-K
7v89ydroyq48r4vdp
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
ct7 bp7wl6n809s
20 Mar 24
Other Events
4:01pm
8-K
g209d2e5a f9hamjjf9
15 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
khhvqd je
22 Feb 24
Entry into a Material Definitive Agreement
4:01pm
8-K
e8ezn bjngskwqpil47
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm
8-K
r33y r8x3h8ry
12 Feb 24
Entry into a Material Definitive Agreement
9:25am
8-K
ypc21x4wr
8 Feb 24
Departure of Directors or Certain Officers
5:07pm
8-K
89axq3zp b1v86sraws
22 Jan 24
Entry into a Material Definitive Agreement
6:12am
8-K
fs9azndi
11 Jan 24
Entry into a Material Definitive Agreement
7:50pm
8-K
cxtxzxje6etb740ci7
8 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K
ieryg3gmrgm3jxgugm5
28 Dec 23
Other Events
4:14pm
8-K
cp3r7h7xy6
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm